Real-World Experience With Proactive Therapeutic Drug Monitoring During Infliximab Reintroduction

BACKGROUND: Interruptions in infliximab therapy are associated with the development of antibodies to infliximab (ATI), infusion reactions (IRs), and loss of response. Despite these challenges, recent observational studies suggest that reinitiating infliximab after a drug holiday can be safe and effe...

Descripción completa

Detalles Bibliográficos
Autores principales: Normatov, Inessa, Fluxa, Daniela, Wang, Jingzhou D, Ollech, Jacob E, Gulotta, George E, Patel, Shivani, Quintero, Maria A, De la Torre, Bety, Solis, Norma, Damas, Oriana M, Deshpande, Amar R, Kerman, David H, Abreu, Maria T, Rubin, David T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Observations and Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802083/
https://www.ncbi.nlm.nih.gov/pubmed/36776674
http://dx.doi.org/10.1093/crocol/otab048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802083/
https://www.ncbi.nlm.nih.gov/pubmed/36776674
http://dx.doi.org/10.1093/crocol/otab048

Ejemplares similares